(Q33928307)

30 July 2017

1 reference

title

Oxidative stress may explain how hypertension is maintained by normal levels of angiotensin II. (English)

1 reference

30 July 2017

J C Romero

1

1 reference

30 July 2017

J F Reckelhoff

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Brazilian Journal of Medical and Biological Research

30 July 2017

published in

1 reference

30 July 2017

volume

33

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

653-660

1 reference

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Arterial hypertension elicited by subpressor amounts of angiotensin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

New insights into the pathophysiology of renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Angiotensin II stimulates synthesis of endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

The isoprostanes: unique bioactive products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Isoprostanes--prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Subpressor angiotensin infusion, renal sodium handling, and salt-induced hypertension in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

Hypertensin: The Substance Causing Renal Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2000000600006

10.1590/S0100-879X2000000600006

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference